Tower Research Capital LLC (Trc) Codiak Bio Sciences, Inc. Transaction History

Tower Research Capital LLC (Trc)

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$0.18 - $0.81 $3,329 - $14,982	-18,497 Reduced 72.08%	7,165 $1,000
Q4 2022 Feb 10, 2023	BUY	$0.32 - $0.9 $6,108 - $17,180	19,089 Added 290.42%	25,662 $10,000
Q3 2022 Nov 10, 2022	BUY	$0.82 - $3.19 $3,099 - $12,058	3,780 Added 135.34%	6,573 $5,000
Q2 2022 Aug 15, 2022	BUY	$2.24 - $6.96 $2,616 - $8,129	1,168 Added 71.88%	2,793 $8,000
Q1 2022 May 12, 2022	SELL	$4.3 - $12.95 $4,011 - $12,082	-933 Reduced 36.47%	1,625 $10,000

Q4 2021 Feb 14, 2022	BUY	$10.0 - $16.78 $19,520 - $32,754	1,952 Added 322.11%	2,558 $28,000
Q3 2021 Nov 15, 2021	SELL	$15.58 - $22.88 $5,343 - $7,847	-343 Reduced 36.14%	606 $10,000
Q2 2021 Aug 16, 2021	BUY	$11.72 - $26.81 $902 - $2,064	77 Added 8.83%	949 $18,000
Q1 2021 May 17, 2021	BUY	$13.49 - $31.53 $4,573 - $10,688	339 Added 63.6%	872 $13,000
Q4 2020 Feb 16, 2021	BUY	$7.9 - $32.3 $4,210 - $17,215	533 New	533 $17,000

238K

Ticker CDAK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,995,200
Market Cap $360K
Description
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.